What does the evidence say about Pomegranate Polyphenols Blood Pressure Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Pomegranate Polyphenols Blood Pressure Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Background : Emerging evidence suggests that polyphenols may contribute to the attenuation of telomere attrition and the upregulation of insulin-like growth factor 1 (IGF-1), primarily in animal and cell studies, and to a lesser extent in humans. [Farhat G (2025); evidence level 2] - Pomegranate extract, known for its high antioxidant capacity, has shown promise in preventing telomere shortening and enhancing IGF-1 levels, but evidence in humans is lacking. [Farhat G (2025); evidence level 2] - Conclusions : Pomegranate extract significantly increased IGF-1 levels and could exert a positive role on vascular ageing. [Farhat G (2025); evidence level 2] - Background : Chronic inflammation increases morbidity in older adults and significantly impacts healthy ageing. [Farhat G (2025); evidence level 2] - Pomegranate extract (PE), rich in polyphenols, has been suggested to reduce inflammation and could prevent cardiovascular disease. [Farhat G (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.